Non Alcoholic Fatty Liver Disease

Journal of Diabetes, 05/07/2012

Weight loss, dietary modification and treatment of underlying metabolic syndrome remain the mainstays of therapy once the diagnosis is established. There are no well–established pharmacological agents for treatment of Non–Alcoholic Steatohepatitis (NASH), although this is a subject of ongoing research.

Print Article Summary Cat 2 CME Report